Brown Miller Wealth Management’s Novo Nordisk NVO Stock Holding History

Brown Miller Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$717K	Buy	14,950 +430	+3%	+$18.5K	0.18%	95
2026 Q1	$534K	Buy	+14,520	New	+$688K	0.15%	115
2025 Q3	–	Sell	-13,658	Closed	-$943K	–	200
2025 Q2	$943K	Buy	13,658 +2,264	+20%	+$154K	0.29%	68
2025 Q1	$791K	Buy	11,394 +3,178	+39%	+$262K	0.27%	71
2024 Q4	$707K	Buy	8,216 +3,908	+91%	+$423K	0.27%	66
2024 Q3	$513K	Buy	4,308 +122	+3%	+$16.3K	0.2%	79
2024 Q2	$598K	Buy	4,186 +30	+0.7%	+$3.98K	0.25%	70
2024 Q1	$534K	Buy	+4,156	New	+$495K	0.24%	77

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Brown Miller Wealth Management's NVO Position: Q2 2026 in Review

Brown Miller Wealth Management increased its Novo Nordisk (NVO) stake by 3% in Q2 2026, buying an estimated $18.5K and bringing the position to 14,950 shares worth $717K. The position accounts for 0.18% of the portfolio, ranked #95.

Brown Miller Wealth Management first reported a position in NVO in Q1 2024 and has held it in 8 quarters since. The position peaked at $943K in Q2 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Brown Miller Wealth Management held 14,950 shares of Novo Nordisk worth $717K as of Q2 2026.
Brown Miller Wealth Management bought 430 Novo Nordisk shares in Q2 2026, an estimated $18.5K.
Novo Nordisk made up 0.18% of Brown Miller Wealth Management's portfolio in Q2 2026, its #95 holding.
Brown Miller Wealth Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 8 quarters since.
Brown Miller Wealth Management's Novo Nordisk position peaked at $943K in Q2 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Brown Miller Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.